260 related articles for article (PubMed ID: 16567971)
1. Anti-alphaGal-dependent complement-mediated cytotoxicity in metastatic melanoma.
Larkin JM; Norsworthy PJ; A'Hern RP; Eisen TG; Gore ME; Porter CD
Melanoma Res; 2006 Apr; 16(2):157-63. PubMed ID: 16567971
[TBL] [Abstract][Full Text] [Related]
2. Characterization of natural human anti-non-gal antibodies and their effect on activation of porcine gal-deficient endothelial cells.
Saethre M; Baumann BC; Fung M; Seebach JD; Mollnes TE
Transplantation; 2007 Jul; 84(2):244-50. PubMed ID: 17667817
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of anti-alphaGalactosyl antibodies predict survival and peritoneal dialysis-related enteric peritonitis rates in patients undergoing renal replacement therapy.
Fontán MP; Máñez R; Rodríguez-Carmona A; Peteiro J; Martínez V; García-Falcón T; Domenech N
Am J Kidney Dis; 2006 Dec; 48(6):972-82. PubMed ID: 17162152
[TBL] [Abstract][Full Text] [Related]
4. Biological variation of anti-αGal-antibodies studied by a novel Time-Resolved ImmunoFluorometric Assay.
Bernth-Jensen JM; Møller BK; Jensenius JC; Thiel S
J Immunol Methods; 2011 Oct; 373(1-2):26-35. PubMed ID: 21835180
[TBL] [Abstract][Full Text] [Related]
5. Complement insufficiency limits efficacy in a xenograft model of hyperacute rejection for cancer therapy.
Larkin JM; Porter CD
Cancer Immunol Immunother; 2007 Jan; 56(1):60-9. PubMed ID: 16715304
[TBL] [Abstract][Full Text] [Related]
6. Human NK cells can lyse porcine endothelial cells independent of their expression of Galalpha(1,3)-Gal and killing is enhanced by activation of either effector or target cells.
Horvath-Arcidiacono JA; Porter CM; Bloom ET
Xenotransplantation; 2006 Jul; 13(4):318-27. PubMed ID: 16768725
[TBL] [Abstract][Full Text] [Related]
7. The serum level of xenoantibodies, and hDAF or alphaGAL expression on pig cells, modulate in vitro the protection given by hDAF to primate complement-mediated damage.
Díaz TM; Mañez R; Moscoso I; López D; Santamarina I; Lopez E; Centeno A; Domenéch N
Transplant Proc; 2005; 37(1):510-1. PubMed ID: 15808692
[TBL] [Abstract][Full Text] [Related]
8. Human DAF on pig cells protects against human and non-human primate sera cytotoxicity mediated by exogenous or endogenous complement, as determined by flow cytometry.
Díaz-Román TM; Mañez R; López-Pelaez E; Centeno A; Moscoso I; Pértegaz S; Doménech N
Transpl Immunol; 2006 Aug; 16(2):125-30. PubMed ID: 16860716
[TBL] [Abstract][Full Text] [Related]
9. Induction of complement attack on human cells by Gal(alpha1,3)Gal xenoantigen expression as a gene therapy approach to cancer.
Jäger U; Takeuchi Y; Porter C
Gene Ther; 1999 Jun; 6(6):1073-83. PubMed ID: 10455410
[TBL] [Abstract][Full Text] [Related]
10. Suppression of Lewis lung tumor development in alpha 1,3 galactosyltransferase knock-out mice.
Posekany KJ; Pittman HK; Swanson MS; Haisch CE; Verbanac KM
Anticancer Res; 2004; 24(2B):605-12. PubMed ID: 15161001
[TBL] [Abstract][Full Text] [Related]
11. Modulation of natural IgM binding and complement activation by natural IgG antibodies: a role for IgG anti-Gal alpha1-3Gal antibodies.
Yu PB; Holzknecht ZE; Bruno D; Parker W; Platt JL
J Immunol; 1996 Dec; 157(11):5163-8. PubMed ID: 8943428
[TBL] [Abstract][Full Text] [Related]
12. Isolation and immunochemical characterization of antibodies from the sera of cancer patients which are reactive against human melanoma cell membranes by affinity chromatography.
Gupta RK; Silver HK; Reisfeld RA; Morton DL
Cancer Res; 1979 May; 39(5):1683-95. PubMed ID: 427806
[TBL] [Abstract][Full Text] [Related]
13. Lack of galactose-alpha-1,3-galactose expression on porcine endothelial cells prevents complement-induced lysis but not direct xenogeneic NK cytotoxicity.
Baumann BC; Forte P; Hawley RJ; Rieben R; Schneider MK; Seebach JD
J Immunol; 2004 May; 172(10):6460-7. PubMed ID: 15128838
[TBL] [Abstract][Full Text] [Related]
14. Reactivity of human natural antibodies to endothelial cells from Galalpha(1,3)Gal-deficient pigs.
Baumann BC; Stussi G; Huggel K; Rieben R; Seebach JD
Transplantation; 2007 Jan; 83(2):193-201. PubMed ID: 17264816
[TBL] [Abstract][Full Text] [Related]
15. Serum cytotoxicity to pig cells and anti-alphaGal antibody level and specificity in humans and baboons.
Neethling FA; Cooper DK
Transplantation; 1999 Mar; 67(5):658-65. PubMed ID: 10096519
[TBL] [Abstract][Full Text] [Related]
16. Neonatal porcine Sertoli cells inhibit human natural antibody-mediated lysis.
Dufour JM; Hamilton M; Rajotte RV; Korbutt GS
Biol Reprod; 2005 May; 72(5):1224-31. PubMed ID: 15659703
[TBL] [Abstract][Full Text] [Related]
17. Failure to deplete anti-Galalpha1-3Gal antibodies after pig-to-baboon organ xenotransplantation by immunoaffinity columns containing multiple Galalpha1-3Gal oligosaccharides.
Mañez R; Domenech N; Centeno A; Lopez-Pelaez E; Crespo F; Juffe A; Duthaler RO; Katopodis AG
Xenotransplantation; 2004 Sep; 11(5):408-15. PubMed ID: 15303977
[TBL] [Abstract][Full Text] [Related]
18. In vivo immunoadsorption of antipig antibodies in baboons using a specific Gal(alpha)1-3Gal column.
Taniguchi S; Neethling FA; Korchagina EY; Bovin N; Ye Y; Kobayashi T; Niekrasz M; Li S; Koren E; Oriol R; Cooper DK
Transplantation; 1996 Nov; 62(10):1379-84. PubMed ID: 8958260
[TBL] [Abstract][Full Text] [Related]
19. Immunoglobulin M-enriched intravenous immunoglobulin inhibits classical pathway complement activation, but not bactericidal activity of human serum.
Walpen AJ; Laumonier T; Aebi C; Mohacsi PJ; Rieben R
Xenotransplantation; 2004 Mar; 11(2):141-8. PubMed ID: 14962276
[TBL] [Abstract][Full Text] [Related]
20. The role of complement receptors in production of antibodies specific for Galalpha1,3Gal.
Kaye J; Bagley J; Malkowski D; Iacomini J
Transplantation; 2004 Jan; 77(2):314-6. PubMed ID: 14743001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
